SCHEMBL6533478

SCHEMBL6533478

COc1ccc(Sc2nc(Nc3cccc(F)c3)nc(N(CCNC(=O)OC(C)(C)C)C(=O)[C@@H](N)CC(C)C)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 4/20 0.36
EGFR P00533 3/20 0.35
CFTR P13569 2/20 0.34
CDC7 O00311 1/20 0.33
CDK19 Q9BWU1 1/20 0.33
CHRNA7 P36544 3/20 0.33
POLB P06746 2/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
MAPK3 P27361 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
SYK P43405 1/20 0.32
HPGD P15428 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6533479 0.87 ITK (0.35) ITKEGFRCFTRCDC7CDK19
SCHEMBL6528181 0.86 TBK1 (0.35) CFTRCDC7CDK19CHRNA7POLB
SCHEMBL6528749 0.85 MEN1 (0.37) CFTRCHRNA7POLBALDH1A1TP53
SCHEMBL6528784 0.84 GALR2 (0.37) CFTRPOLBSYK
SCHEMBL6531461 0.83 EGFR (0.39) EGFRCFTRCHRNA7POLBALDH1A1
SCHEMBL6528279 0.83 GALR2 (0.38) SYK
SCHEMBL6529648 0.83 PDPK1 (0.41) EGFRPOLBTSHRMEN1KMT2A
SCHEMBL6529551 0.82 CHRNA7 (0.35) CFTRCHRNA7POLBALDH1A1KDM4E
SCHEMBL6530876 0.82 MAPT (0.38) EGFRPOLBALDH1A1TSHRSMN1; SMN2
SCHEMBL6530216 0.81 NPC1 (0.38) ITKEGFRPOLBALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed